High dose IVIG (+/- Rituximab) desensitization alters sCD30 and BAFF levels in highly HLA sensitized patients

被引：0
|
作者：
Lai, Chih-Hung [1 ]
Vo, Ashley [1 ]
Toyoda, Mieko [1 ]
Jordan, Stanley [1 ]
Reinsmoen, Nancy L. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA 90048 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2008年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
下载
收藏
页码：473 / 473
页数：1
相关论文
共 50 条
  • [41] Successful Kidney Transplantation After Repeat Desensitization Using Plasmapheresis, Low-Dose Intravenous Immunoglobulin, Rituximab, and Bortezomib in a Highly HLA-Sensitized and ABO Incompatible Patient: A Case Report
    Inui, M.
    Miyazato, T.
    Furusawa, M.
    Tanabe, K.
    TRANSPLANTATION, 2014, 98 : 453 - 453
  • [42] Successful Kidney Transplantation After Repeat Desensitization Using Plasmapheresis, Low-Dose Intravenous Immunoglobulin, Rituximab, and Bortezomib in a Highly HLA-Sensitized and ABO Incompatible Patient: A Case Report
    Inui, M.
    Miyazato, T.
    Furusawa, M.
    Tanabe, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 453 - 453
  • [43] IVIg plus Rituximab Desensitization ( DES) Combined with Alemtuzumab (ATZ) Induction Does Not Increase Risk for Viral Infections (VIs) and Associated Complications in HLA-Sensitized (HS) Kidney Transplant Patients (KTx Pts)
    Ge, S.
    Shin, B. -H.
    Mirocha, J.
    Thomas, D.
    Chu, M.
    Rodriguez, E.
    Chao, C.
    Petrosyan, A.
    Galera, O.
    Vo, A.
    Choi, J.
    Peng, A.
    Kahwaji, J.
    Jordan, S.
    Toyoda, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 354 - 354
  • [44] Intravenous Immunoglobulin and Rituximab Desensitization (IVIG-Ritux-DES) Allows Successful Transplantation (Tx) without Affecting Total Immunoglobulin (Ig), Anti-CMV IgG and CMV-Specific Cytotoxic T Cell (CMV-Tc) Levels in Highly HLA-Sensitized Patients (HS Pts)
    Ge, Shili
    Pao, Andy
    Vo, Ashley
    Deer, Nathan
    Karasyov, Artur
    Lukovsky, Marina
    Petrosyan, Anna
    Mirocha, James
    Aguiluz, Angela
    Jordan, Stanley C.
    Toyoda, Mieko
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 220 - 220
  • [45] Long term graft and patient outcomes in highly-HLA sensitized (HS) deceased donor (DD) kidney transplant (KT) recipients desensitized with high dose (HD) IVIG.
    Peng, Alice
    Vo, Ashley
    Villicana, Rafael
    Dafoe, Donald
    Reinsmoen, Nancy
    Jordan, Stanley
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 303 - 303
  • [46] NR1I2 8055 Gene Polymorphism of Pregnane X Nuclear Receptor Is Not a Risk Factor for Polyomavirus BK (BKV) Infection in HLA-Sensitized (HS) Patients Transplanted After Desensitization With IVIG and Rituximab
    Kahwaji, J.
    Thomas, D.
    Chu, M.
    Barbosa, D.
    Puliyanda, D.
    Vo, A.
    Jordan, S.
    Toyoda, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 551 - 551
  • [47] NR1I2 8055 Gene Polymorphism of Pregnane X Nuclear Receptor Is Not a Risk Factor for Polyomavirus BK (BKV) Infection in HLA-Sensitized (HS) Patients Transplanted After Desensitization With IVIG and Rituximab.
    Kahwaji, J.
    Thomas, D.
    Chu, M.
    Barbosa, D.
    Puliyanda, D.
    Vo, A.
    Jordan, S.
    Toyoda, M.
    TRANSPLANTATION, 2014, 98 : 551 - 551
  • [48] Desensitization Regimen Consisting of High-Dose Intravenous Immunoglobulin, Plasmapheresis, and Rituximab (an Anti-CD20 Antibody), Without Eculizumab and/or Bortezomib, in 41 Highly Sensitized Kidney Transplant Recipients
    Ishida, Hideki
    Unagami, Kohei
    Omoto, Kazuya
    Kanzawa, Taichi
    Tanabe, Kazunari
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2021, 19 (10) : 1032 - 1040
  • [49] High anti-endothelial cell antibody (AECA) levels decrease transplantability and graft survival in highly HLA-sensitized ESRD patients.
    Rodich, GS
    Petrosyan, A
    McIntosh, M
    Jordan, SC
    Toyoda, M
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 258 - 258
  • [50] Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide
    Garnier, Alice
    Delbos, Florent
    Guillaume, Thierry
    Peterlin, Pierre
    Le Bourgeois, Amandine
    Bene, Marie C.
    Le Bris, Yannick
    Malard, Stephanie
    Duquesne, Alix
    Gauvrit, Isabelle
    Moreau, Philippe
    Cesbron, Anne
    Chevallier, Patrice
    BONE MARROW TRANSPLANTATION, 2018, 53 (08) : 1044 - 1047
12345